by Kim Brebach | Oct 23, 2026 | Featured Post, Heart Health
STAREE is the latest clinical trial of a cholesterol-lowering statin drug to treat or prevent heart disease. The trial drug is Atorvastatin (commercial name ‘Lipitor’), the oldest and highest-selling statin drug. I dig into this ‘world-first’...
by Kim Brebach | Apr 20, 2026 | Brain Health
A recent review of anti-amyloid drugs to treat Alzheimer’s Disease was critical of their meagre performance. It drew indignation from some, but shouldn’t have. The link between reducing amyloid plaques (see pic above) and improving dementia has been questioned for...
by Kim Brebach | Apr 10, 2026 | Brain Health
Early enthusiasm for the new dementia drugs, lecanemab and donamab, hasn’t been matched by enthusiasm by governments around the world to pick up the tab. I find out why. Main Points ‘Symptom-modifying’ drugs have been around for more than 20 years;...
by Kim Brebach | Mar 16, 2026 | Featured Post, Heart Health
If you read this headline recently, ‘Statins, the world’s most prescribed cholesterol drugs, not responsible for most reported side effects’, you’d probably say ‘statin side effects aren’t serious’. It was the headline of the press release for a...
by Kim Brebach | Mar 10, 2026 | Brain Health, Featured Post
If you google ‘can you reverse dementia’ you’ll get hundreds of results with variations of ‘No. You can only slow the rate of cognitive decline or ease symptoms until the disease progresses’, so you may think I’m the one who’s lost my marbles. In this blog...